Jack Wu

Jack Wu, PhD, MBA, currently serves as SD of Search & Evaluation in Global Oncology at Takeda since June 2024. Prior to this role, Jack was the Head of Business Development Search & Evaluation at Antengene from September 2020 to February 2024, contributing to the company's innovative oncology medicines. Jack also held the position of Head of Business Development (USA) at Adlai Nortye from July 2018 to September 2020, focusing on the development and commercialization of new oncology drugs. Additionally, Jack served as Manager of Commercial Partnerships at ATCC from November 2015 to July 2018 and as Manager of the Department of Sales and Marketing in Discovery Biology at GenScript from January 2011 to November 2015. Educational qualifications include an MBA from Columbia Business School, a PhD from North Carolina State University, and a Bachelor of Science from Xiamen University.